Trade Trends of m/s syntro pty ltd

from Jan 2022 to Sept 2025
Shipments Imported: 0
As Buyer Trade Value (USD): $0
Shipments Exported: 2
As Supplier Trade Value (USD): $1.62 K

Import and Export shipments of "m/s syntro pty ltd"

As Supplier
Consignee NameShipper NameHS CodeShipment Weight (kg)Product KeywordsShipment Date
3004900.8
Medicines (For use in clinical trials in Uzbekistan) 1) A combination drug consisting of the active substance: Nirmatrelvir 150 mg; Ritonavir 100 mg, (PAXLOVID) tablets - 12 boxes, Manufacturer: Pfizer, Ireland. (A drug used to treat mild to moderate COVID-19 in adults): weight: 0.8 kg; 2) Type and quantity of packaging: 1 thermal container; 8) Investment program code: 000; 11) Public procurement indicator: 02;
Nov 17, 2025
ooo sharq clin trials
m/s syntro pty ltd
3004900.8
Medicines (For use in clinical trials in Uzbekistan) 1) A combination drug consisting of the active substance: Nirmatrelvir 150 mg; Ritonavir 100 mg, (PAXLOVID) tablets - 12 boxes, Manufacturer: Pfizer, Ireland. (A drug used to treat mild to moderate COVID-19 in adults): weight: 0.8 kg; 2) Type and quantity of packaging: 1 thermal container; 8) Investment program code: 000; 11) Public procurement indicator: 02;
Nov 17, 2025
ooo sharq clin trials
m/s syntro pty ltd
3004900.8
Medicines (For use in clinical trials in Uzbekistan) 1) A combination drug consisting of the active substance: Nirmatrelvir 150 mg; Ritonavir 100 mg, (PAXLOVID) tablets - 12 boxes, Manufacturer: Pfizer, Ireland. (A drug used to treat mild to moderate COVID-19 in adults): weight: 0.8 kg; 2) Type and quantity of packaging: 1 thermal container; 8) Investment program code: 000; 11) Public procurement indicator: 02;
Nov 17, 2025
ooo sharq clin trials
m/s syntro pty ltd
3004900.8
Medicines (For use in clinical trials in Uzbekistan) 1) A combination drug consisting of the active substance: Nirmatrelvir 150 mg; Ritonavir 100 mg, (PAXLOVID) tablets - 12 boxes, Manufacturer: Pfizer, Ireland. (A drug used to treat mild to moderate COVID-19 in adults): weight: 0.8 kg; 2) Type and quantity of packaging: 1 thermal container; 8) Investment program code: 000; 11) Public procurement indicator: 02;
Nov 17, 2025
ooo sharq clin trials
m/s syntro pty ltd
3004900.8
Medicines (For use in clinical trials in Uzbekistan) 1) A combination drug consisting of the active substance: Nirmatrelvir 150 mg; Ritonavir 100 mg, (PAXLOVID) tablets - 12 boxes, Manufacturer: Pfizer, Ireland. (A drug used to treat mild to moderate COVID-19 in adults): weight: 0.8 kg; 2) Type and quantity of packaging: 1 thermal container; 8) Investment program code: 000; 11) Public procurement indicator: 02;
Nov 17, 2025
Premium Content Locked

Trademo turns 3B+ shipment records and 15M+ company profiles into actionable data for trade prospecting. Subscribe to Trademo Intel to grow the pipeline.

Trading Partners of m/s syntro pty ltd

Top Companies "m/s syntro pty ltd" is exporting to (by Value USD)

Buyer2025
ooo sharq clin trials
1.62 K

Markets in which m/s syntro pty ltd trades

Top Countries "m/s syntro pty ltd" is exporting to (by Value USD)

Importing Country2025
country flagsuzbekistan
1.62 K

Products/HS Codes traded by m/s syntro pty ltd

Top HS Codes Exported by "m/s syntro pty ltd"

USD 1.62 K | 100.00%

Pharmaceutical products Medicaments (excluding goods of heading 30.02, 30.05 or 30.06) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale. - Other

Intel
Identify in-market buyers, prioritize high-potential accounts, and accelerate pipeline growth.
Subscribe to Intel Now→

Similar Companies to m/s syntro pty ltd

Companies exporting similar HS Codes as of "m/s syntro pty ltd" in australia

Other Buyers and Suppliers in australia who deal in similar products like m/s syntro pty ltd